Clinical Research Directory

Inclusion Criteria: * Generally healthy participants with a life expectancy ≥ 5 years * Male and female participants aged 50 to 80 years * Body Mass Index (BMI) between 25 to 35 kg/m² * Health not severely compromised (no life-threatening illness or disability) Participants with: * Intrinsic Capacity score showing mild to moderate decline * Short Physical Performance Battery (SPPB) score between 9 to 11 * Montreal Cognitive Assessment (MoCA) score \> 20 and ≤ 25 * Participants with or without comorbidities; if present, must be on a stable treatment regimen (same drug and dose) for at least 12 weeks prior to screening * Able and willing to: * Provide written informed consent * Comply with study protocol requirements * Read and write in English Exclusion Criteria: * Severe or uncontrolled chronic diseases (e.g., severe osteoarthritis, advanced cardiovascular disease, kidney failure, uncontrolled diabetes, severe COPD, terminal cancer) * Physical disability requiring a walker or wheelchair * Diagnosed dementia or cognitive impairment preventing protocol compliance * Acute infection or illness within 3 months prior to enrollment * Unstable medical conditions (e.g., recent myocardial infarction, unstable angina, uncontrolled hypertension) * Major surgery within the past 6 months or planned during the study * Severe psychiatric disorders unless well controlled * Substance abuse within the past 6 months * Participation in another clinical trial within the last 6 months * Known allergy to any component of the nutraceutical kit * Sedentary individuals unable or not advised to undergo resistance training as per protocol * Clinically relevant macro- or micronutrient deficiency (as per investigator discretion) * Pregnant or lactating women * Women of childbearing potential not using adequate contraception or with a positive urine pregnancy test * Current use of herbal products, nutraceuticals, Ayurvedic formulations, dietary supplements, or vitamin/mineral supplements and unwilling to discontinue during the study * Any other condition or abnormal laboratory finding that, in the investigator's opinion, may interfere with study results or participant safety